314 related articles for article (PubMed ID: 22289106)
1. Elevated BIS and Entropy values after sugammadex or neostigmine: an electroencephalographic or electromyographic phenomenon?
Aho AJ; Kamata K; Yli-Hankala A; Lyytikäinen LP; Kulkas A; Jäntti V
Acta Anaesthesiol Scand; 2012 Apr; 56(4):465-73. PubMed ID: 22289106
[TBL] [Abstract][Full Text] [Related]
2. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/remifentanil anaesthesia.
Dahaba AA; Bornemann H; Hopfgartner E; Ohran M; Kocher K; Liebmann M; Wilfinger G; Metzler H
Br J Anaesth; 2012 Apr; 108(4):602-6. PubMed ID: 22315331
[TBL] [Abstract][Full Text] [Related]
3. Reversal of neuromuscular blockade by sugammadex does not affect EEG derived indices of depth of anesthesia.
Illman H; Antila H; Olkkola KT
J Clin Monit Comput; 2010 Oct; 24(5):371-6. PubMed ID: 20734116
[TBL] [Abstract][Full Text] [Related]
4. Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial.
Schepens T; Janssens K; Maes S; Wildemeersch D; Vellinga J; Jorens PG; Saldien V
BMC Anesthesiol; 2019 Oct; 19(1):187. PubMed ID: 31629404
[TBL] [Abstract][Full Text] [Related]
5. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
6. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
[TBL] [Abstract][Full Text] [Related]
7. Electromyographic activity of the diaphragm during neostigmine or sugammadex-enhanced recovery after neuromuscular blockade with rocuronium: a randomised controlled study in healthy volunteers.
Schepens T; Cammu G; Saldien V; De Neve N; Jorens PG; Foubert L; Vercauteren M
Eur J Anaesthesiol; 2015 Jan; 32(1):49-57. PubMed ID: 25111539
[TBL] [Abstract][Full Text] [Related]
8. Can electromyographic arousal be detected visually on the Datex-Ohmeda S/5™ anesthesia monitor?
Aho AJ; Yli-Hankala A; Lyytikäinen LP; Kamata K; Jäntti V
Acta Anaesthesiol Scand; 2013 Mar; 57(3):364-72. PubMed ID: 22928590
[TBL] [Abstract][Full Text] [Related]
9. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.
Rex C; Wagner S; Spies C; Scholz J; Rietbergen H; Heeringa M; Wulf H
Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873
[TBL] [Abstract][Full Text] [Related]
10. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
[TBL] [Abstract][Full Text] [Related]
11. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block.
Schaller SJ; Fink H; Ulm K; Blobner M
Anesthesiology; 2010 Nov; 113(5):1054-60. PubMed ID: 20885293
[TBL] [Abstract][Full Text] [Related]
12. The effect of neuromuscular block and noxious stimulation on hypnosis monitoring during sevoflurane anesthesia.
Ekman A; Stålberg E; Sundman E; Eriksson LI; Brudin L; Sandin R
Anesth Analg; 2007 Sep; 105(3):688-95. PubMed ID: 17717224
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effect of electromyogram activity during emergence on anesthetic depth monitoring between phase lag entropy and bispectral index: a prospective observational study.
Kim TK; Shin SW; Kim HJ; Choi EJ; Park S; Kim SH; Yoo YM; Kim HY
Ann Palliat Med; 2022 Apr; 11(4):1290-1296. PubMed ID: 34328012
[TBL] [Abstract][Full Text] [Related]
14. Effects of neuromuscular blockade reversal on bispectral index and frontal electromyogram during steady-state desflurane anesthesia: a randomized trial.
Kim D; Ahn JH; Jung H; Choi KY; Jeong JS
Sci Rep; 2019 Jul; 9(1):10486. PubMed ID: 31324862
[TBL] [Abstract][Full Text] [Related]
15. A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US.
Jiang Y; Bash LD; Saager L
Adv Ther; 2021 May; 38(5):2689-2708. PubMed ID: 33871823
[TBL] [Abstract][Full Text] [Related]
16. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
Abrishami A; Ho J; Wong J; Yin L; Chung F
Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
[TBL] [Abstract][Full Text] [Related]
17. The influence of neuromuscular blockade on phase lag entropy and bispectral index: A randomized, controlled trial.
Jin S; Baik HJ; Cho S; Chung RK; Kong KA; Kim YJ
PLoS One; 2021; 16(9):e0257467. PubMed ID: 34520506
[TBL] [Abstract][Full Text] [Related]
18. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
Pühringer FK; Rex C; Sielenkämper AW; Claudius C; Larsen PB; Prins ME; Eikermann M; Khuenl-Brady KS
Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227
[TBL] [Abstract][Full Text] [Related]
19. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
Bash LD; Turzhitsky V; Black W; Urman RD
Adv Ther; 2021 Sep; 38(9):4736-4755. PubMed ID: 34319550
[TBL] [Abstract][Full Text] [Related]
20. Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns.
Bash LD; Black W; Turzhitsky V; Urman RD
Anesth Analg; 2021 Dec; 133(6):1437-1450. PubMed ID: 34784330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
